Healthcare professionals and patients in a clinical setting

Having CAR T-cell therapy

There are a few stages when you have CAR T-cell therapy. In this information, we’ll explain each of these stages so you know exactly what to expect.

What’s on this page?

What happens during CAR-T therapy?

You’ll go through some preparation first before having CAR T-cell therapy. You can read more about this on our Preparing for CAR T-cell therapy webpage.

There are three main stages of having CAR-T therapy:

  1. Collecting your T cells using an apheresis machine
  2. Making your CAR T-cells in a laboratory
  3. Infusion day, when your new CAR T-cells are put into your bloodstream

We’ll explain each of these stages in detail on this webpage.

Collecting your T cells

Your T cells will be collected during a common procedure called leukapheresis. It may need to be done over two days to make sure enough T cells are collected.

  1. You'll have a needle and thin tube (cannula) put into a vein in each arm (or you may have a central line in your chest or groin).
  2. Your blood will be taken out of one arm and go into an apheresis machine.
  3. The apheresis machine will separate your T cells from the rest of your blood.
  4. The rest of your blood will be returned to your other arm.
  5. Your T cells are then sent to the laboratory where your treatment is made.

This procedure can take a few hours so remember to bring things to keep you busy, like a book, a tablet or laptop, or hobbies. You can read more ideas on our Preparing for CAR T-cell therapy webpage.

You might feel a bit tired during or after leukapheresis, but you should feel OK otherwise. Make sure you tell your medical team if you have any worries or feel uncomfortable at any time.

Remember:

You might not be able to move your arms much if you have a cannula in each arm. This is worth remembering when thinking of things to keep you busy! An e-reader may be easier to use than turning the pages of a book, for example.

Making your CAR T-cells

Your T cells will be sent to a laboratory to form your treatment. You can read more about what this means on our What is CAR T-cell therapy? webpage.

At the laboratory:

  1. Scientists will create your new CAR T-cells by modifying the DNA of your T cells.
  2. The cells will then be grown until there are enough of them to form your treatment. This can take a few weeks.
  3. When your CAR T-cells are ready, they will be frozen and sent back to the hospital, ready for you to receive.

You might have bridging treatment while your CAR T-cells are being made.

You will also have a course of chemotherapy about a week before you receive your CAR T-cells. This is called lymphodepletion.

Read more about bridging treatment and chemotherapy on our Preparing for CAR T-cell therapy webpage.

Important:

Occasionally, the laboratory isn’t able to manufacture the CAR T-cells successfully. If this happens then your doctor will discuss options with you.

Infusion day

You will receive your CAR T-cells in hospital. Your CAR T-cells will be thawed (defrosted) and a specially trained nurse will give them to you through your central line, PICC line or cannula. This is called infusion. It’s a similar process to having a blood transfusion and should take about 15-30 minutes.

You will be given medication before the infusion to prevent any allergic reactions or fevers.

Important:

Infusion day might feel simple and quite anticlimactic. Remember that it’s still an important day! Make sure you are kind to yourself and celebrate, even in a small way. Your medical team are always happy to chat about how you’re feeling and answer any questions, too.

I was anxious before starting the therapy. The doctors and specialist nurse reassured me, telling me that even though they couldn’t say how exactly I’d respond to the treatment, they would be able to deal with any side effects I might have. Despite having some side effects, they were well managed, and I’m now currently in remission.

Sandra, who had CAR T-cell therapy to treat high grade diffuse large B cell lymphoma
Blood Cancer UK logo

Information published: 30/08/2024
Next review due: 30/08/2027